Target intelligence / Profile preview

Alpha-amylase and alpha-glucosidase (α-Amylase and α-Glucosidase)

Target
α-Amylase and α-Glucosidase
Molecular classification
Enzyme, Glycoside hydrolase, Glycoside hydrolase family 13 (GH13), Glycoside hydrolase family 31 (GH31)
01

Overview

Alpha-amylase is a calcium-dependent enzyme produced in the salivary glands and pancreas that catalyzes the random cleavage of internal α-1,4-glycosidic bonds in polysaccharides like starch and glycogen, producing oligosaccharides and maltose. It is characterized by a (β/α)₈ barrel fold and belongs to the glycoside hydrolase family 13. Alpha-glucosidase is situated on the luminal surface of intestinal epithelial cells and hydrolyzes terminal, non-reducing α-1,4-linked glucose residues from disaccharides and oligosaccharides, releasing free glucose; it is classified in glycoside hydrolase family 31. Both enzymes facilitate the digestive process of carbohydrates, and their inhibition by drugs such as acarbose and miglitol forms the basis of a therapeutic approach to slow glucose absorption and control postprandial hyperglycemia in type 2 diabetes patients. Deficiencies in alpha-glucosidase are associated with specific glycogen storage diseases such as Pompe disease, while their physiological role is central in overall metabolic homeostasis and dietary glucose uptake.

Other names
1,4-α-D-glucan glucanohydrolaseglycogenaseEC 3.2.1.1maltaseglucoamylasesucrase-isomaltaseEC 3.2.1.20
02

Mechanism of action

Competitive inhibition of enzyme active sites, thereby delaying carbohydrate digestion and glucose absorption, resulting in reduced postprandial blood glucose levels

03

Biological functions

Carbohydrate digestionHydrolysis of glycosidic linkagesRelease of glucose for absorption and metabolism
04

Disease associations

Diabetes (esp. type 2 diabetes)Glycogen storage diseases (specific to alpha-glucosidase deficiency)
05

Safety considerations

Gastrointestinal side effects (e.g., flatulence, diarrhea, bloating) due to undigested carbohydrates reaching the colonPossible hepatotoxicity and elevated transaminases (less common; monitor during therapy)
06

Interacting drugs

Acarbose

2 more in the full profile.

07

Biomarkers

Blood glucose levelHbA1c (glycated hemoglobin)

Beyond the preview

Go deeper on Alpha-amylase and alpha-glucosidase (α-Amylase and α-Glucosidase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-amylase and alpha-glucosidase (α-Amylase and α-Glucosidase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call